Abstract:Background Human gut microbiota plays an important role in the pathogenesis of cirrhosis complications. Although the phylogenetic diversity of intestinal microbiota in patients with liver cirrhosis has been examined in several studies, little is known about their functional composition and structure. Results To characterize the functional gene diversity of the gut microbiome in cirrhotic patients, we recruited a total of 42 individuals, 12 alcoholic cirrhosis patients, 18 hepatitis B virus (HBV)-related cirrhosis patients, and 12 normal controls. We determined the functional structure of these samples using a specific functional gene array, which is a combination of GeoChip for monitoring biogeochemical processes and HuMiChip specifically designed for analyzing human microbiomes. Our experimental data showed that the microbial community functional composition and structure were dramatically distinctive in the alcoholic cirrhosis. Various microbial functional genes involved in organic remediation, stress response, antibiotic resistance, metal resistance, and virulence were highly enriched in the alcoholic cirrhosis group compared to the control group and HBV-related cirrhosis group. Cirrhosis may have distinct influences on metabolic potential of fecal microbial communities. The abundance of functional genes relevant to nutrient metabolism, including amino acid metabolism, lipid metabolism, nucleotide metabolism, and isoprenoid biosynthesis, were significantly decreased in both alcoholic cirrhosis group and HBV-related cirrhosis group. Significant correlations were observed between functional gene abundances and Child-Pugh scores, such as those encoding aspartate-ammonia ligase, transaldolase, adenylosuccinate synthetase and IMP dehydrogenase. Conclusions Functional gene array was utilized to study the gut microbiome in alcoholic and HBV-related cirrhosis patients and controls in this study. Our array data indicated that the functional composition of fecal microbiomes was heavily influenced by cirrhosis, especially by alcoholic cirrhosis. This study provides new insights into the functional potentials and activity of gut microbiota in cirrhotic patients with different etiologies.

Intestinal virome: An important research direction for alcoholic and nonalcoholic liver diseases

Tiny but Mighty: Possible Roles of Bacterial Extracellular Vesicles in Gut‐liver Crosstalk for Non‐alcoholic Fatty Liver Disease

Gut Microbiome, Liver Immunology, and Liver Diseases

Infectious Microecology in Liver Disease

Intestinal virome and therapeutic potential of bacteriophages in liver disease

Intestinal Virome Signature Associated With Severity of Nonalcoholic Fatty Liver Disease.

Functional gene arrays-based analysis of fecal microbiomes in patients with liver cirrhosis

Gut virome in inflammatory bowel disease and beyond

The Role of Gut Microbiota in Some Liver Diseases: From an Immunological Perspective

The gut virome: A new microbiome component in health and disease

Human Gut Microbiome and Liver Diseases: From Correlation to Causation

Disorganized Gut Microbiome Contributed to Liver Cirrhosis Progression: A Meta-Omics-Based Study

Alterations of the gut microbiota associated with the occurrence and progression of viral hepatitis

Role of Intestinal Microbes in Chronic Liver Diseases

Novel approaches to intervene gut microbiota in the treatment of chronic liver diseases

The Novel Role of Phage Particles in Chronic Liver Diseases

The role of the microbiome in liver disease

The Human Gut Virome and Its Relationship with Nontransmissible Chronic Diseases

Gut microbiota in alcohol-related liver disease: pathophysiology and gut-brain cross talk

Dynamic impact of virome on colitis and colorectal cancer: Immunity, inflammation, prevention and treatment

Alcohol or Gut Microbiota: Who Is the Guilty?